// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A novel method to determine left atrial compliance in vivo: relationship with markers of remodelling in AF

RJ Norton - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Reducing the burden of unnecessary LINQ implantable loop recorder remote downloads by implementing an in-hospital multidisciplinary strategy to individualise management of patients with high volume downloads

JH Tan - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implantable loop recorders - diagnostic yield in patients with syncope and presyncope

R Adlakha - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Internal loop recorder (‘Reveal’) implantation as a diagnostic tool in patients with unexplained syncope

Jipin Das Kizhakkepatt - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Atrial flutter in hospital practice: the burden of atrial flutter on a regional cardioversion service, and barriers to referral for ablation

S A Reddy - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Do octogenarians tolerate CRT-P insertion?

FGD Smith - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Day-case device implantation- a prospective single-centre experience including patient satisfaction data

JL Peplow - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

A retrospective study to assess feasibility of daycase complex device insertion

FGD Smith - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implantable cardiac monitors (ICM): quality assurance audit outcomes of an innovative specialist nurse led service.

T Rice - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Remote monitoring of implantable cardioverter-defibrillators: can usage be predicted at a UK tertiary centre?

C Gannon - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Investigation of the transmural action potential duration and repolarization properties of scar borderzone in patients undergoing ventricular tachycardia ablation

NT Srinivasan - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Supporting initiation of anticoagulation with ‘jack’, a video counselling tool

Sharron Gordon - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

P wave duration and spectral analysis of signal averaged P wave: can this guide us in deciding the extent of af ablation required beyond pulmonary vein isolation? - A prospective study

S Varanasi - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Cardiopulmonary exercise testing echocardiography features predicting the safety and efficacy of a central arterio-venous fistula with subgroup analysis assessing the impact of the device on blood pressure control and AF burden

WJT Eysenck - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

CMRI-assessed left ventricular extra-cellular volume fraction, not left atrial late gadolinium uptake, is related to higher left atrial pressure and increased type 1 collagen telopeptide levels in pre-ablation AF patients

G A Begg - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Improving the implementation of anti-coagulation therapy in AF patients at risk of stroke in a primary care setting

S.E Agdomar - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

The prevalence of upgrade to biventricular pacing after bradycardia pacing is less than 2%: a 12-year series of over 750 patients from a ‘real world’ district general cohort

Steven E Williams - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Implantable cardioverter defibrillator use in octogenarians

A Sotiriou - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

AV delay optimisation in patients with congenitally corrected transposition of the great arteries.

SJ Griffiths - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

ECG predictors of ventricular arrhythmia and non arrhythmic death in the subcutaneous implantable cardioverter defibrillator population

BM Wiles - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved